TCL Archive Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change? January 20, 2006
Institutions Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer October 25, 2021
TCL Archive Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering September 3, 2010
TCL Archive Flint Chop Shows That Successful Community Program Can Be Developed And Operated Without NCI Funding January 21, 1983
TCL Archive Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects April 30, 2010
